Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
{{output}}
Glioblastoma, the most common and aggressive primary brain tumor, remains a significant challenge in oncology due to its immunosuppressive tumor microenvironment (TME). This review summarizes the complex interplay of immune cells and cytokines within the TME, ... ...
